Evidence map›Paper›PMID 34376262›Full record

ArticleJournal of the International Neuropsychological Society : JINS2022

Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico.

Miguel Arce Rentería, Jennifer J Manly, Jet M J Vonk, Silvia Mejia Arango, Alejandra Michaels Obregon, Rafael Samper-Ternent, Rebeca Wong, Sandra Barral, Giuseppe Tosto

Open access · greenAbstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Differential Improvement in Memory and Executive Functions: Personalized Exercise versus Acupuncture for Mild Cognitive Impairment in Stroke-prone Individuals.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Care Need, Caregiver Availability, and Care Receipt: Variations Across Countries and Over Time in Three Middle-Income Countries.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  13. [Cognitive function groups in older people and risk factors].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Miguel Arce RenteríaTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.ORCID 0000-0002-4696-6279
Jennifer J ManlyTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.ORCID 0000-0002-9481-7497
Jet M J VonkTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.
Silvia Mejia ArangoDepartment of Population Studies, El Colegio de la Frontera Norte, Tijuana, Baja California, Mexico.
Alejandra Michaels ObregonSealy Center on Aging, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Rafael Samper-TernentSealy Center on Aging, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Rebeca WongSealy Center on Aging, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Sandra BarralTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.
Giuseppe TostoTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, USA.
Columbia University · USThe University of Texas Medical Branch at Galveston · USEl Colegio de la Frontera Norte · MXUtrecht University · NL

Funding

The Mexican Health and Aging Study - IIR01AG018016 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Rebeca Wong · 1999 to 2026
$22.6M
Genetics of Alzheimer's Disease in MexicoR56AG059756 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARRAL RODRIGUEZ, SANDRA, MAYEUX, RICHARD P · 2018 to 2019
$5.0M
Whole genome sequencing of the Mexican Health Aging Study (MHAS) cohortR56AG066889 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARRAL RODRIGUEZ, SANDRA, TOSTO, GIUSEPPE · 2020 to 2020
$1.6M
MHAS Cognitive Aging Ancillary Study Administrative SupplementR01AG051158 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WONG, REBECA · 2015 to 2017
$1.1M
Factors of Resilience to Alzheimers Disease and Related Dementias among Latinx: The Role of BilingualismR00AG066932 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ARCE, MIGUEL · 2023 to 2025
$938k
Factors of Resilience to Alzheimers Disease and Related Dementias among Latinx: The Role of BilingualismK99AG066932 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ARCE, MIGUEL · 2020 to 2021
$261k
NIA NIH HHS K99 AG066932NIA NIH HHS R00 AG066932NIA NIH HHS R01 AG018016NIA NIH HHS R01 AG051158NIA NIH HHS R56 AG059756NIA NIH HHS R56 AG066889
6 · The paper itself

Abstract

objectiveTo estimate the prevalence of mild cognitive impairment (MCI) and its subtypes and investigate the impact of midlife cardiovascular risk factors on late-life MCI among the aging Mexican population.

methodAnalyses included a sample of non-demented adults over the age of 55 living in both urban and rural areas of Mexico (N = 1807). MCI diagnosis was assigned based on a comprehensive cognitive assessment assessing the domains of memory, executive functioning, language, and visuospatial ability. The normative sample was selected by means of the robust norms approach. Cognitive impairment was defined by a 1.5-SD cut-off per cognitive domain using normative corrections for age, years of education, and sex. Risk factors included age, education, sex, rurality, depression, insurance status, workforce status, hypertension, diabetes, stroke, and heart disease.

resultsThe prevalence of amnestic MCI was 5.9%. Other MCI subtypes ranged from 4.2% to 7.7%. MCI with and without memory impairment was associated with older age (OR = 1.01 [1.01, 1.05]; OR = 1.03 [1.01, 1.04], respectively) and residing in rural areas (OR = 1.49 [1.08, 2.06]; OR = 1.35 [1.03, 1.77], respectively). Depression (OR = 1.07 [1.02, 1.12]), diabetes (OR = 1.37 [1.03, 1.82]), and years of education (OR = 0.94 [0.91, 0.97]) were associated with MCI without memory impairment. Midlife CVD increased the odds of MCI in late-life (OR = 1.76 [1.19, 2.59], which was driven by both midlife hypertension and diabetes (OR = 1.70 [1.18, 2.44]; OR = 1.88 [1.19, 2.97], respectively).

conclusionsOlder age, depression, low education, rurality, and midlife hypertension and diabetes were associated with higher risk of late-life MCI among older adults in Mexico. Our findings suggest that the causes of cognitive impairment are multifactorial and vary by MCI subtype.

Indexed as

Cognitive DysfunctionHypertensionAgedHumansMemory DisordersMexicoNeuropsychological TestsPrevalenceRisk FactorsCognitive agingMex-CogMexican populationMHASMild cognitive impairmentNeuropsychology

Identifiers

PMID34376262
PMCPMC8831650
OpenAlexW3187346640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.